ZHU Jun. Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas: Results of the NHL-B1 Trial of the DSHNHL[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 15-17. DOI: 10.3969/j.issn.1671-5144.2007.01.006
|
Citation:
|
ZHU Jun. Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas: Results of the NHL-B1 Trial of the DSHNHL[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 15-17. DOI: 10.3969/j.issn.1671-5144.2007.01.006
|
ZHU Jun. Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas: Results of the NHL-B1 Trial of the DSHNHL[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 15-17. DOI: 10.3969/j.issn.1671-5144.2007.01.006
|
Citation:
|
ZHU Jun. Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas: Results of the NHL-B1 Trial of the DSHNHL[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 15-17. DOI: 10.3969/j.issn.1671-5144.2007.01.006
|
DownLoad: